Global Cell Therapy CMO Market Growth (Status and Outlook) 2026-2032
The global Cell Therapy CMO market size is predicted to grow from US$ 2827 million in 2025 to US$ 4617 million in 2032; it is expected to grow at a CAGR of 7.2% from 2026 to 2032.
Cell Therapy CMO is an organization that provides professional, large-scale manufacturing outsourcing services to cell therapy drug development companies. The core of this service lies in helping clients transform their laboratory-scale cell preparation processes into industrial-scale production processes that comply with Good Manufacturing Practices (GMP), solving key challenges in the industrialization of cell therapies, such as process development, quality control, and regulatory compliance. Services cover the entire manufacturing chain of autologous and allogeneic cell therapy products, including viral vector production, cell collection and isolation, gene modification, cell expansion and activation, formulation filling, cryopreservation and transportation, and quality control and release testing. Relying on standardized GMP cleanrooms, closed automated culture systems, and a rigorous quality management system, the CMO ensures the stability, safety, and efficacy of cell products across different batches, thereby accelerating the transition of cell therapy from clinical research to commercial application.
The global Cell Therapy CMO market for cell therapy is experiencing rapid growth driven by the proliferation of cell therapy pipelines and the demand for commercialization. North America and Europe, as mature markets, leverage their leading viral vector technologies, robust GMP systems, and extensive CDMO experience to hold leading positions in the commercial production of autologous CAR-T cells, large-scale lentiviral manufacturing, and closed-loop automated platforms. The Asia-Pacific region has become the fastest-growing and most rapidly expanding sector. China, with its leading global number of cell therapy clinical studies, strong policy support, and cost advantages across the supply chain, is driving the rapid rise of autologous cell therapy CMOs, general-purpose cell manufacturing, and viral vector outsourcing services, with domestic CMOs quickly gaining a competitive edge globally. The industry as a whole is accelerating its evolution towards fully closed-loop automated production, off-the-shelf cell technologies, and a globalized supply chain.
LPI (LP Information)' newest research report, the “Cell Therapy CMO Industry Forecast” looks at past sales and reviews total world Cell Therapy CMO sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell Therapy CMO sales for 2026 through 2032. With Cell Therapy CMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Therapy CMO industry.
This Insight Report provides a comprehensive analysis of the global Cell Therapy CMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Therapy CMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Therapy CMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Therapy CMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Therapy CMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Therapy CMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
Cell Therapy CMO is an organization that provides professional, large-scale manufacturing outsourcing services to cell therapy drug development companies. The core of this service lies in helping clients transform their laboratory-scale cell preparation processes into industrial-scale production processes that comply with Good Manufacturing Practices (GMP), solving key challenges in the industrialization of cell therapies, such as process development, quality control, and regulatory compliance. Services cover the entire manufacturing chain of autologous and allogeneic cell therapy products, including viral vector production, cell collection and isolation, gene modification, cell expansion and activation, formulation filling, cryopreservation and transportation, and quality control and release testing. Relying on standardized GMP cleanrooms, closed automated culture systems, and a rigorous quality management system, the CMO ensures the stability, safety, and efficacy of cell products across different batches, thereby accelerating the transition of cell therapy from clinical research to commercial application.
The global Cell Therapy CMO market for cell therapy is experiencing rapid growth driven by the proliferation of cell therapy pipelines and the demand for commercialization. North America and Europe, as mature markets, leverage their leading viral vector technologies, robust GMP systems, and extensive CDMO experience to hold leading positions in the commercial production of autologous CAR-T cells, large-scale lentiviral manufacturing, and closed-loop automated platforms. The Asia-Pacific region has become the fastest-growing and most rapidly expanding sector. China, with its leading global number of cell therapy clinical studies, strong policy support, and cost advantages across the supply chain, is driving the rapid rise of autologous cell therapy CMOs, general-purpose cell manufacturing, and viral vector outsourcing services, with domestic CMOs quickly gaining a competitive edge globally. The industry as a whole is accelerating its evolution towards fully closed-loop automated production, off-the-shelf cell technologies, and a globalized supply chain.
LPI (LP Information)' newest research report, the “Cell Therapy CMO Industry Forecast” looks at past sales and reviews total world Cell Therapy CMO sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell Therapy CMO sales for 2026 through 2032. With Cell Therapy CMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Therapy CMO industry.
This Insight Report provides a comprehensive analysis of the global Cell Therapy CMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Therapy CMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Therapy CMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Therapy CMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Therapy CMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Therapy CMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Open-type CMO
- Closed-type CMO
- Autologous Cell Therapy
- Universal Cell Therapy
- Xenogeneic Cell Therapy
- Immunotherapy CMO
- Stem Cell Therapy CMO
- Somatic Cell Therapy CMO
- Others
- Commercial
- Academic Research
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen Inc.
- Dendreon Pharmaceuticals LLC.
- Fibrocell Science, Inc
- Lonza
- Charles River Laboratories
- Cytiva
- Catalent Biologics
- FUJIFILM Diosynth Biotechnologies
- Made Scientific
- AGC Biologics
- Pfizer CentreOne
- Samsung Biologics
- Kite Pharma, Inc.
- Kolon TissueGene, Inc.
- Novartis AG
- WuXi AppTec
- Pharmaron
- OBiO
- Exothera
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell Therapy CMO Market Size (2021-2032)
2.1.2 Cell Therapy CMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cell Therapy CMO by Country/Region (2021, 2025 & 2032)
2.2 Cell Therapy CMO Segment by Type
2.2.1 Open-type CMO
2.2.2 Closed-type CMO
2.2.3 Cell Therapy CMO Market Size by Type
2.2.3.1 Cell Therapy CMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Cell Therapy CMO Market Size Market Share by Type (2021-2026)
2.3 Cell Therapy CMO Segment by Cell Source
2.3.1 Autologous Cell Therapy
2.3.2 Universal Cell Therapy
2.3.3 Xenogeneic Cell Therapy
2.3.4 Cell Therapy CMO Market Size by Cell Source
2.3.4.1 Cell Therapy CMO Market Size CAGR by Cell Source (2021 VS 2025 VS 2032)
2.3.4.2 Global Cell Therapy CMO Market Size Market Share by Cell Source (2021-2026)
2.4 Cell Therapy CMO Segment by Cell Types
2.4.1 Immunotherapy CMO
2.4.2 Stem Cell Therapy CMO
2.4.3 Somatic Cell Therapy CMO
2.4.4 Others
2.4.5 Cell Therapy CMO Market Size by Cell Types
2.4.5.1 Cell Therapy CMO Market Size CAGR by Cell Types (2021 VS 2025 VS 2032)
2.4.5.2 Global Cell Therapy CMO Market Size Market Share by Cell Types (2021-2026)
2.5 Cell Therapy CMO Segment by Application
2.5.1 Commercial
2.5.2 Academic Research
2.5.3 Others
2.5.4 Cell Therapy CMO Market Size by Application
2.5.4.1 Cell Therapy CMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Cell Therapy CMO Market Size Market Share by Application (2021-2026)
3 CELL THERAPY CMO MARKET SIZE BY PLAYER
3.1 Cell Therapy CMO Market Size Market Share by Player
3.1.1 Global Cell Therapy CMO Revenue by Player (2021-2026)
3.1.2 Global Cell Therapy CMO Revenue Market Share by Player (2021-2026)
3.2 Global Cell Therapy CMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL THERAPY CMO BY REGION
4.1 Cell Therapy CMO Market Size by Region (2021-2026)
4.2 Global Cell Therapy CMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cell Therapy CMO Market Size Growth (2021-2026)
4.4 APAC Cell Therapy CMO Market Size Growth (2021-2026)
4.5 Europe Cell Therapy CMO Market Size Growth (2021-2026)
4.6 Middle East & Africa Cell Therapy CMO Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cell Therapy CMO Market Size by Country (2021-2026)
5.2 Americas Cell Therapy CMO Market Size by Type (2021-2026)
5.3 Americas Cell Therapy CMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Therapy CMO Market Size by Region (2021-2026)
6.2 APAC Cell Therapy CMO Market Size by Type (2021-2026)
6.3 APAC Cell Therapy CMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell Therapy CMO Market Size by Country (2021-2026)
7.2 Europe Cell Therapy CMO Market Size by Type (2021-2026)
7.3 Europe Cell Therapy CMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell Therapy CMO by Region (2021-2026)
8.2 Middle East & Africa Cell Therapy CMO Market Size by Type (2021-2026)
8.3 Middle East & Africa Cell Therapy CMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL THERAPY CMO MARKET FORECAST
10.1 Global Cell Therapy CMO Forecast by Region (2027-2032)
10.1.1 Global Cell Therapy CMO Forecast by Region (2027-2032)
10.1.2 Americas Cell Therapy CMO Forecast
10.1.3 APAC Cell Therapy CMO Forecast
10.1.4 Europe Cell Therapy CMO Forecast
10.1.5 Middle East & Africa Cell Therapy CMO Forecast
10.2 Americas Cell Therapy CMO Forecast by Country (2027-2032)
10.2.1 United States Market Cell Therapy CMO Forecast
10.2.2 Canada Market Cell Therapy CMO Forecast
10.2.3 Mexico Market Cell Therapy CMO Forecast
10.2.4 Brazil Market Cell Therapy CMO Forecast
10.3 APAC Cell Therapy CMO Forecast by Region (2027-2032)
10.3.1 China Cell Therapy CMO Market Forecast
10.3.2 Japan Market Cell Therapy CMO Forecast
10.3.3 Korea Market Cell Therapy CMO Forecast
10.3.4 Southeast Asia Market Cell Therapy CMO Forecast
10.3.5 India Market Cell Therapy CMO Forecast
10.3.6 Australia Market Cell Therapy CMO Forecast
10.4 Europe Cell Therapy CMO Forecast by Country (2027-2032)
10.4.1 Germany Market Cell Therapy CMO Forecast
10.4.2 France Market Cell Therapy CMO Forecast
10.4.3 UK Market Cell Therapy CMO Forecast
10.4.4 Italy Market Cell Therapy CMO Forecast
10.4.5 Russia Market Cell Therapy CMO Forecast
10.5 Middle East & Africa Cell Therapy CMO Forecast by Region (2027-2032)
10.5.1 Egypt Market Cell Therapy CMO Forecast
10.5.2 South Africa Market Cell Therapy CMO Forecast
10.5.3 Israel Market Cell Therapy CMO Forecast
10.5.4 Turkey Market Cell Therapy CMO Forecast
10.6 Global Cell Therapy CMO Forecast by Type (2027-2032)
10.7 Global Cell Therapy CMO Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cell Therapy CMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Information
11.1.2 Amgen Inc. Cell Therapy CMO Product Offered
11.1.3 Amgen Inc. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Amgen Inc. Main Business Overview
11.1.5 Amgen Inc. Latest Developments
11.2 Dendreon Pharmaceuticals LLC.
11.2.1 Dendreon Pharmaceuticals LLC. Company Information
11.2.2 Dendreon Pharmaceuticals LLC. Cell Therapy CMO Product Offered
11.2.3 Dendreon Pharmaceuticals LLC. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Dendreon Pharmaceuticals LLC. Main Business Overview
11.2.5 Dendreon Pharmaceuticals LLC. Latest Developments
11.3 Fibrocell Science, Inc
11.3.1 Fibrocell Science, Inc Company Information
11.3.2 Fibrocell Science, Inc Cell Therapy CMO Product Offered
11.3.3 Fibrocell Science, Inc Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Fibrocell Science, Inc Main Business Overview
11.3.5 Fibrocell Science, Inc Latest Developments
11.4 Lonza
11.4.1 Lonza Company Information
11.4.2 Lonza Cell Therapy CMO Product Offered
11.4.3 Lonza Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Lonza Main Business Overview
11.4.5 Lonza Latest Developments
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Information
11.5.2 Charles River Laboratories Cell Therapy CMO Product Offered
11.5.3 Charles River Laboratories Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Charles River Laboratories Main Business Overview
11.5.5 Charles River Laboratories Latest Developments
11.6 Cytiva
11.6.1 Cytiva Company Information
11.6.2 Cytiva Cell Therapy CMO Product Offered
11.6.3 Cytiva Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Cytiva Main Business Overview
11.6.5 Cytiva Latest Developments
11.7 Catalent Biologics
11.7.1 Catalent Biologics Company Information
11.7.2 Catalent Biologics Cell Therapy CMO Product Offered
11.7.3 Catalent Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Catalent Biologics Main Business Overview
11.7.5 Catalent Biologics Latest Developments
11.8 FUJIFILM Diosynth Biotechnologies
11.8.1 FUJIFILM Diosynth Biotechnologies Company Information
11.8.2 FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Product Offered
11.8.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.8.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.9 Made Scientific
11.9.1 Made Scientific Company Information
11.9.2 Made Scientific Cell Therapy CMO Product Offered
11.9.3 Made Scientific Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Made Scientific Main Business Overview
11.9.5 Made Scientific Latest Developments
11.10 AGC Biologics
11.10.1 AGC Biologics Company Information
11.10.2 AGC Biologics Cell Therapy CMO Product Offered
11.10.3 AGC Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 AGC Biologics Main Business Overview
11.10.5 AGC Biologics Latest Developments
11.11 Pfizer CentreOne
11.11.1 Pfizer CentreOne Company Information
11.11.2 Pfizer CentreOne Cell Therapy CMO Product Offered
11.11.3 Pfizer CentreOne Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Pfizer CentreOne Main Business Overview
11.11.5 Pfizer CentreOne Latest Developments
11.12 Samsung Biologics
11.12.1 Samsung Biologics Company Information
11.12.2 Samsung Biologics Cell Therapy CMO Product Offered
11.12.3 Samsung Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Samsung Biologics Main Business Overview
11.12.5 Samsung Biologics Latest Developments
11.13 Kite Pharma, Inc.
11.13.1 Kite Pharma, Inc. Company Information
11.13.2 Kite Pharma, Inc. Cell Therapy CMO Product Offered
11.13.3 Kite Pharma, Inc. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Kite Pharma, Inc. Main Business Overview
11.13.5 Kite Pharma, Inc. Latest Developments
11.14 Kolon TissueGene, Inc.
11.14.1 Kolon TissueGene, Inc. Company Information
11.14.2 Kolon TissueGene, Inc. Cell Therapy CMO Product Offered
11.14.3 Kolon TissueGene, Inc. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Kolon TissueGene, Inc. Main Business Overview
11.14.5 Kolon TissueGene, Inc. Latest Developments
11.15 Novartis AG
11.15.1 Novartis AG Company Information
11.15.2 Novartis AG Cell Therapy CMO Product Offered
11.15.3 Novartis AG Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Novartis AG Main Business Overview
11.15.5 Novartis AG Latest Developments
11.16 WuXi AppTec
11.16.1 WuXi AppTec Company Information
11.16.2 WuXi AppTec Cell Therapy CMO Product Offered
11.16.3 WuXi AppTec Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 WuXi AppTec Main Business Overview
11.16.5 WuXi AppTec Latest Developments
11.17 Pharmaron
11.17.1 Pharmaron Company Information
11.17.2 Pharmaron Cell Therapy CMO Product Offered
11.17.3 Pharmaron Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Pharmaron Main Business Overview
11.17.5 Pharmaron Latest Developments
11.18 OBiO
11.18.1 OBiO Company Information
11.18.2 OBiO Cell Therapy CMO Product Offered
11.18.3 OBiO Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 OBiO Main Business Overview
11.18.5 OBiO Latest Developments
11.19 Exothera
11.19.1 Exothera Company Information
11.19.2 Exothera Cell Therapy CMO Product Offered
11.19.3 Exothera Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Exothera Main Business Overview
11.19.5 Exothera Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell Therapy CMO Market Size (2021-2032)
2.1.2 Cell Therapy CMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cell Therapy CMO by Country/Region (2021, 2025 & 2032)
2.2 Cell Therapy CMO Segment by Type
2.2.1 Open-type CMO
2.2.2 Closed-type CMO
2.2.3 Cell Therapy CMO Market Size by Type
2.2.3.1 Cell Therapy CMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Cell Therapy CMO Market Size Market Share by Type (2021-2026)
2.3 Cell Therapy CMO Segment by Cell Source
2.3.1 Autologous Cell Therapy
2.3.2 Universal Cell Therapy
2.3.3 Xenogeneic Cell Therapy
2.3.4 Cell Therapy CMO Market Size by Cell Source
2.3.4.1 Cell Therapy CMO Market Size CAGR by Cell Source (2021 VS 2025 VS 2032)
2.3.4.2 Global Cell Therapy CMO Market Size Market Share by Cell Source (2021-2026)
2.4 Cell Therapy CMO Segment by Cell Types
2.4.1 Immunotherapy CMO
2.4.2 Stem Cell Therapy CMO
2.4.3 Somatic Cell Therapy CMO
2.4.4 Others
2.4.5 Cell Therapy CMO Market Size by Cell Types
2.4.5.1 Cell Therapy CMO Market Size CAGR by Cell Types (2021 VS 2025 VS 2032)
2.4.5.2 Global Cell Therapy CMO Market Size Market Share by Cell Types (2021-2026)
2.5 Cell Therapy CMO Segment by Application
2.5.1 Commercial
2.5.2 Academic Research
2.5.3 Others
2.5.4 Cell Therapy CMO Market Size by Application
2.5.4.1 Cell Therapy CMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Cell Therapy CMO Market Size Market Share by Application (2021-2026)
3 CELL THERAPY CMO MARKET SIZE BY PLAYER
3.1 Cell Therapy CMO Market Size Market Share by Player
3.1.1 Global Cell Therapy CMO Revenue by Player (2021-2026)
3.1.2 Global Cell Therapy CMO Revenue Market Share by Player (2021-2026)
3.2 Global Cell Therapy CMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL THERAPY CMO BY REGION
4.1 Cell Therapy CMO Market Size by Region (2021-2026)
4.2 Global Cell Therapy CMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cell Therapy CMO Market Size Growth (2021-2026)
4.4 APAC Cell Therapy CMO Market Size Growth (2021-2026)
4.5 Europe Cell Therapy CMO Market Size Growth (2021-2026)
4.6 Middle East & Africa Cell Therapy CMO Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cell Therapy CMO Market Size by Country (2021-2026)
5.2 Americas Cell Therapy CMO Market Size by Type (2021-2026)
5.3 Americas Cell Therapy CMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Therapy CMO Market Size by Region (2021-2026)
6.2 APAC Cell Therapy CMO Market Size by Type (2021-2026)
6.3 APAC Cell Therapy CMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell Therapy CMO Market Size by Country (2021-2026)
7.2 Europe Cell Therapy CMO Market Size by Type (2021-2026)
7.3 Europe Cell Therapy CMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell Therapy CMO by Region (2021-2026)
8.2 Middle East & Africa Cell Therapy CMO Market Size by Type (2021-2026)
8.3 Middle East & Africa Cell Therapy CMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL THERAPY CMO MARKET FORECAST
10.1 Global Cell Therapy CMO Forecast by Region (2027-2032)
10.1.1 Global Cell Therapy CMO Forecast by Region (2027-2032)
10.1.2 Americas Cell Therapy CMO Forecast
10.1.3 APAC Cell Therapy CMO Forecast
10.1.4 Europe Cell Therapy CMO Forecast
10.1.5 Middle East & Africa Cell Therapy CMO Forecast
10.2 Americas Cell Therapy CMO Forecast by Country (2027-2032)
10.2.1 United States Market Cell Therapy CMO Forecast
10.2.2 Canada Market Cell Therapy CMO Forecast
10.2.3 Mexico Market Cell Therapy CMO Forecast
10.2.4 Brazil Market Cell Therapy CMO Forecast
10.3 APAC Cell Therapy CMO Forecast by Region (2027-2032)
10.3.1 China Cell Therapy CMO Market Forecast
10.3.2 Japan Market Cell Therapy CMO Forecast
10.3.3 Korea Market Cell Therapy CMO Forecast
10.3.4 Southeast Asia Market Cell Therapy CMO Forecast
10.3.5 India Market Cell Therapy CMO Forecast
10.3.6 Australia Market Cell Therapy CMO Forecast
10.4 Europe Cell Therapy CMO Forecast by Country (2027-2032)
10.4.1 Germany Market Cell Therapy CMO Forecast
10.4.2 France Market Cell Therapy CMO Forecast
10.4.3 UK Market Cell Therapy CMO Forecast
10.4.4 Italy Market Cell Therapy CMO Forecast
10.4.5 Russia Market Cell Therapy CMO Forecast
10.5 Middle East & Africa Cell Therapy CMO Forecast by Region (2027-2032)
10.5.1 Egypt Market Cell Therapy CMO Forecast
10.5.2 South Africa Market Cell Therapy CMO Forecast
10.5.3 Israel Market Cell Therapy CMO Forecast
10.5.4 Turkey Market Cell Therapy CMO Forecast
10.6 Global Cell Therapy CMO Forecast by Type (2027-2032)
10.7 Global Cell Therapy CMO Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cell Therapy CMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Information
11.1.2 Amgen Inc. Cell Therapy CMO Product Offered
11.1.3 Amgen Inc. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Amgen Inc. Main Business Overview
11.1.5 Amgen Inc. Latest Developments
11.2 Dendreon Pharmaceuticals LLC.
11.2.1 Dendreon Pharmaceuticals LLC. Company Information
11.2.2 Dendreon Pharmaceuticals LLC. Cell Therapy CMO Product Offered
11.2.3 Dendreon Pharmaceuticals LLC. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Dendreon Pharmaceuticals LLC. Main Business Overview
11.2.5 Dendreon Pharmaceuticals LLC. Latest Developments
11.3 Fibrocell Science, Inc
11.3.1 Fibrocell Science, Inc Company Information
11.3.2 Fibrocell Science, Inc Cell Therapy CMO Product Offered
11.3.3 Fibrocell Science, Inc Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Fibrocell Science, Inc Main Business Overview
11.3.5 Fibrocell Science, Inc Latest Developments
11.4 Lonza
11.4.1 Lonza Company Information
11.4.2 Lonza Cell Therapy CMO Product Offered
11.4.3 Lonza Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Lonza Main Business Overview
11.4.5 Lonza Latest Developments
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Information
11.5.2 Charles River Laboratories Cell Therapy CMO Product Offered
11.5.3 Charles River Laboratories Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Charles River Laboratories Main Business Overview
11.5.5 Charles River Laboratories Latest Developments
11.6 Cytiva
11.6.1 Cytiva Company Information
11.6.2 Cytiva Cell Therapy CMO Product Offered
11.6.3 Cytiva Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Cytiva Main Business Overview
11.6.5 Cytiva Latest Developments
11.7 Catalent Biologics
11.7.1 Catalent Biologics Company Information
11.7.2 Catalent Biologics Cell Therapy CMO Product Offered
11.7.3 Catalent Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Catalent Biologics Main Business Overview
11.7.5 Catalent Biologics Latest Developments
11.8 FUJIFILM Diosynth Biotechnologies
11.8.1 FUJIFILM Diosynth Biotechnologies Company Information
11.8.2 FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Product Offered
11.8.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.8.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.9 Made Scientific
11.9.1 Made Scientific Company Information
11.9.2 Made Scientific Cell Therapy CMO Product Offered
11.9.3 Made Scientific Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Made Scientific Main Business Overview
11.9.5 Made Scientific Latest Developments
11.10 AGC Biologics
11.10.1 AGC Biologics Company Information
11.10.2 AGC Biologics Cell Therapy CMO Product Offered
11.10.3 AGC Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 AGC Biologics Main Business Overview
11.10.5 AGC Biologics Latest Developments
11.11 Pfizer CentreOne
11.11.1 Pfizer CentreOne Company Information
11.11.2 Pfizer CentreOne Cell Therapy CMO Product Offered
11.11.3 Pfizer CentreOne Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Pfizer CentreOne Main Business Overview
11.11.5 Pfizer CentreOne Latest Developments
11.12 Samsung Biologics
11.12.1 Samsung Biologics Company Information
11.12.2 Samsung Biologics Cell Therapy CMO Product Offered
11.12.3 Samsung Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Samsung Biologics Main Business Overview
11.12.5 Samsung Biologics Latest Developments
11.13 Kite Pharma, Inc.
11.13.1 Kite Pharma, Inc. Company Information
11.13.2 Kite Pharma, Inc. Cell Therapy CMO Product Offered
11.13.3 Kite Pharma, Inc. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Kite Pharma, Inc. Main Business Overview
11.13.5 Kite Pharma, Inc. Latest Developments
11.14 Kolon TissueGene, Inc.
11.14.1 Kolon TissueGene, Inc. Company Information
11.14.2 Kolon TissueGene, Inc. Cell Therapy CMO Product Offered
11.14.3 Kolon TissueGene, Inc. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Kolon TissueGene, Inc. Main Business Overview
11.14.5 Kolon TissueGene, Inc. Latest Developments
11.15 Novartis AG
11.15.1 Novartis AG Company Information
11.15.2 Novartis AG Cell Therapy CMO Product Offered
11.15.3 Novartis AG Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Novartis AG Main Business Overview
11.15.5 Novartis AG Latest Developments
11.16 WuXi AppTec
11.16.1 WuXi AppTec Company Information
11.16.2 WuXi AppTec Cell Therapy CMO Product Offered
11.16.3 WuXi AppTec Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 WuXi AppTec Main Business Overview
11.16.5 WuXi AppTec Latest Developments
11.17 Pharmaron
11.17.1 Pharmaron Company Information
11.17.2 Pharmaron Cell Therapy CMO Product Offered
11.17.3 Pharmaron Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Pharmaron Main Business Overview
11.17.5 Pharmaron Latest Developments
11.18 OBiO
11.18.1 OBiO Company Information
11.18.2 OBiO Cell Therapy CMO Product Offered
11.18.3 OBiO Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 OBiO Main Business Overview
11.18.5 OBiO Latest Developments
11.19 Exothera
11.19.1 Exothera Company Information
11.19.2 Exothera Cell Therapy CMO Product Offered
11.19.3 Exothera Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Exothera Main Business Overview
11.19.5 Exothera Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cell Therapy CMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cell Therapy CMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Open-type CMO
Table 4. Major Players of Closed-type CMO
Table 5. Cell Therapy CMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Cell Therapy CMO Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Cell Therapy CMO Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Autologous Cell Therapy
Table 9. Major Players of Universal Cell Therapy
Table 10. Major Players of Xenogeneic Cell Therapy
Table 11. Cell Therapy CMO Market Size CAGR by Cell Source (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Cell Therapy CMO Market Size by Cell Source (2021-2026) & ($ millions)
Table 13. Global Cell Therapy CMO Market Size Market Share by Cell Source (2021-2026)
Table 14. Major Players of Immunotherapy CMO
Table 15. Major Players of Stem Cell Therapy CMO
Table 16. Major Players of Somatic Cell Therapy CMO
Table 17. Major Players of Others
Table 18. Cell Therapy CMO Market Size CAGR by Cell Types (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Cell Therapy CMO Market Size by Cell Types (2021-2026) & ($ millions)
Table 20. Global Cell Therapy CMO Market Size Market Share by Cell Types (2021-2026)
Table 21. Cell Therapy CMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Cell Therapy CMO Market Size by Application (2021-2026) & ($ millions)
Table 23. Global Cell Therapy CMO Market Size Market Share by Application (2021-2026)
Table 24. Global Cell Therapy CMO Revenue by Player (2021-2026) & ($ millions)
Table 25. Global Cell Therapy CMO Revenue Market Share by Player (2021-2026)
Table 26. Cell Therapy CMO Key Players Head office and Products Offered
Table 27. Cell Therapy CMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Cell Therapy CMO Market Size by Region (2021-2026) & ($ millions)
Table 31. Global Cell Therapy CMO Market Size Market Share by Region (2021-2026)
Table 32. Global Cell Therapy CMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Cell Therapy CMO Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Cell Therapy CMO Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas Cell Therapy CMO Market Size Market Share by Country (2021-2026)
Table 36. Americas Cell Therapy CMO Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas Cell Therapy CMO Market Size Market Share by Type (2021-2026)
Table 38. Americas Cell Therapy CMO Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas Cell Therapy CMO Market Size Market Share by Application (2021-2026)
Table 40. APAC Cell Therapy CMO Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC Cell Therapy CMO Market Size Market Share by Region (2021-2026)
Table 42. APAC Cell Therapy CMO Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC Cell Therapy CMO Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe Cell Therapy CMO Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe Cell Therapy CMO Market Size Market Share by Country (2021-2026)
Table 46. Europe Cell Therapy CMO Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe Cell Therapy CMO Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa Cell Therapy CMO Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa Cell Therapy CMO Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa Cell Therapy CMO Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of Cell Therapy CMO
Table 52. Key Market Challenges & Risks of Cell Therapy CMO
Table 53. Key Industry Trends of Cell Therapy CMO
Table 54. Global Cell Therapy CMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global Cell Therapy CMO Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global Cell Therapy CMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global Cell Therapy CMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Amgen Inc. Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 59. Amgen Inc. Cell Therapy CMO Product Offered
Table 60. Amgen Inc. Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Amgen Inc. Main Business
Table 62. Amgen Inc. Latest Developments
Table 63. Dendreon Pharmaceuticals LLC. Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 64. Dendreon Pharmaceuticals LLC. Cell Therapy CMO Product Offered
Table 65. Dendreon Pharmaceuticals LLC. Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Dendreon Pharmaceuticals LLC. Main Business
Table 67. Dendreon Pharmaceuticals LLC. Latest Developments
Table 68. Fibrocell Science, Inc Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 69. Fibrocell Science, Inc Cell Therapy CMO Product Offered
Table 70. Fibrocell Science, Inc Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Fibrocell Science, Inc Main Business
Table 72. Fibrocell Science, Inc Latest Developments
Table 73. Lonza Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 74. Lonza Cell Therapy CMO Product Offered
Table 75. Lonza Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Lonza Main Business
Table 77. Lonza Latest Developments
Table 78. Charles River Laboratories Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 79. Charles River Laboratories Cell Therapy CMO Product Offered
Table 80. Charles River Laboratories Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Charles River Laboratories Main Business
Table 82. Charles River Laboratories Latest Developments
Table 83. Cytiva Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 84. Cytiva Cell Therapy CMO Product Offered
Table 85. Cytiva Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Cytiva Main Business
Table 87. Cytiva Latest Developments
Table 88. Catalent Biologics Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 89. Catalent Biologics Cell Therapy CMO Product Offered
Table 90. Catalent Biologics Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Catalent Biologics Main Business
Table 92. Catalent Biologics Latest Developments
Table 93. FUJIFILM Diosynth Biotechnologies Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 94. FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Product Offered
Table 95. FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. FUJIFILM Diosynth Biotechnologies Main Business
Table 97. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 98. Made Scientific Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 99. Made Scientific Cell Therapy CMO Product Offered
Table 100. Made Scientific Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Made Scientific Main Business
Table 102. Made Scientific Latest Developments
Table 103. AGC Biologics Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 104. AGC Biologics Cell Therapy CMO Product Offered
Table 105. AGC Biologics Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. AGC Biologics Main Business
Table 107. AGC Biologics Latest Developments
Table 108. Pfizer CentreOne Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 109. Pfizer CentreOne Cell Therapy CMO Product Offered
Table 110. Pfizer CentreOne Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Pfizer CentreOne Main Business
Table 112. Pfizer CentreOne Latest Developments
Table 113. Samsung Biologics Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 114. Samsung Biologics Cell Therapy CMO Product Offered
Table 115. Samsung Biologics Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Samsung Biologics Main Business
Table 117. Samsung Biologics Latest Developments
Table 118. Kite Pharma, Inc. Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 119. Kite Pharma, Inc. Cell Therapy CMO Product Offered
Table 120. Kite Pharma, Inc. Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Kite Pharma, Inc. Main Business
Table 122. Kite Pharma, Inc. Latest Developments
Table 123. Kolon TissueGene, Inc. Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 124. Kolon TissueGene, Inc. Cell Therapy CMO Product Offered
Table 125. Kolon TissueGene, Inc. Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Kolon TissueGene, Inc. Main Business
Table 127. Kolon TissueGene, Inc. Latest Developments
Table 128. Novartis AG Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 129. Novartis AG Cell Therapy CMO Product Offered
Table 130. Novartis AG Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Novartis AG Main Business
Table 132. Novartis AG Latest Developments
Table 133. WuXi AppTec Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 134. WuXi AppTec Cell Therapy CMO Product Offered
Table 135. WuXi AppTec Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. WuXi AppTec Main Business
Table 137. WuXi AppTec Latest Developments
Table 138. Pharmaron Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 139. Pharmaron Cell Therapy CMO Product Offered
Table 140. Pharmaron Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 141. Pharmaron Main Business
Table 142. Pharmaron Latest Developments
Table 143. OBiO Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 144. OBiO Cell Therapy CMO Product Offered
Table 145. OBiO Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 146. OBiO Main Business
Table 147. OBiO Latest Developments
Table 148. Exothera Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 149. Exothera Cell Therapy CMO Product Offered
Table 150. Exothera Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 151. Exothera Main Business
Table 152. Exothera Latest Developments
Table 1. Cell Therapy CMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cell Therapy CMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Open-type CMO
Table 4. Major Players of Closed-type CMO
Table 5. Cell Therapy CMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Cell Therapy CMO Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Cell Therapy CMO Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Autologous Cell Therapy
Table 9. Major Players of Universal Cell Therapy
Table 10. Major Players of Xenogeneic Cell Therapy
Table 11. Cell Therapy CMO Market Size CAGR by Cell Source (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Cell Therapy CMO Market Size by Cell Source (2021-2026) & ($ millions)
Table 13. Global Cell Therapy CMO Market Size Market Share by Cell Source (2021-2026)
Table 14. Major Players of Immunotherapy CMO
Table 15. Major Players of Stem Cell Therapy CMO
Table 16. Major Players of Somatic Cell Therapy CMO
Table 17. Major Players of Others
Table 18. Cell Therapy CMO Market Size CAGR by Cell Types (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Cell Therapy CMO Market Size by Cell Types (2021-2026) & ($ millions)
Table 20. Global Cell Therapy CMO Market Size Market Share by Cell Types (2021-2026)
Table 21. Cell Therapy CMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Cell Therapy CMO Market Size by Application (2021-2026) & ($ millions)
Table 23. Global Cell Therapy CMO Market Size Market Share by Application (2021-2026)
Table 24. Global Cell Therapy CMO Revenue by Player (2021-2026) & ($ millions)
Table 25. Global Cell Therapy CMO Revenue Market Share by Player (2021-2026)
Table 26. Cell Therapy CMO Key Players Head office and Products Offered
Table 27. Cell Therapy CMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Cell Therapy CMO Market Size by Region (2021-2026) & ($ millions)
Table 31. Global Cell Therapy CMO Market Size Market Share by Region (2021-2026)
Table 32. Global Cell Therapy CMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Cell Therapy CMO Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Cell Therapy CMO Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas Cell Therapy CMO Market Size Market Share by Country (2021-2026)
Table 36. Americas Cell Therapy CMO Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas Cell Therapy CMO Market Size Market Share by Type (2021-2026)
Table 38. Americas Cell Therapy CMO Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas Cell Therapy CMO Market Size Market Share by Application (2021-2026)
Table 40. APAC Cell Therapy CMO Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC Cell Therapy CMO Market Size Market Share by Region (2021-2026)
Table 42. APAC Cell Therapy CMO Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC Cell Therapy CMO Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe Cell Therapy CMO Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe Cell Therapy CMO Market Size Market Share by Country (2021-2026)
Table 46. Europe Cell Therapy CMO Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe Cell Therapy CMO Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa Cell Therapy CMO Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa Cell Therapy CMO Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa Cell Therapy CMO Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of Cell Therapy CMO
Table 52. Key Market Challenges & Risks of Cell Therapy CMO
Table 53. Key Industry Trends of Cell Therapy CMO
Table 54. Global Cell Therapy CMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global Cell Therapy CMO Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global Cell Therapy CMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global Cell Therapy CMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Amgen Inc. Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 59. Amgen Inc. Cell Therapy CMO Product Offered
Table 60. Amgen Inc. Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Amgen Inc. Main Business
Table 62. Amgen Inc. Latest Developments
Table 63. Dendreon Pharmaceuticals LLC. Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 64. Dendreon Pharmaceuticals LLC. Cell Therapy CMO Product Offered
Table 65. Dendreon Pharmaceuticals LLC. Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Dendreon Pharmaceuticals LLC. Main Business
Table 67. Dendreon Pharmaceuticals LLC. Latest Developments
Table 68. Fibrocell Science, Inc Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 69. Fibrocell Science, Inc Cell Therapy CMO Product Offered
Table 70. Fibrocell Science, Inc Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Fibrocell Science, Inc Main Business
Table 72. Fibrocell Science, Inc Latest Developments
Table 73. Lonza Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 74. Lonza Cell Therapy CMO Product Offered
Table 75. Lonza Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Lonza Main Business
Table 77. Lonza Latest Developments
Table 78. Charles River Laboratories Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 79. Charles River Laboratories Cell Therapy CMO Product Offered
Table 80. Charles River Laboratories Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Charles River Laboratories Main Business
Table 82. Charles River Laboratories Latest Developments
Table 83. Cytiva Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 84. Cytiva Cell Therapy CMO Product Offered
Table 85. Cytiva Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Cytiva Main Business
Table 87. Cytiva Latest Developments
Table 88. Catalent Biologics Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 89. Catalent Biologics Cell Therapy CMO Product Offered
Table 90. Catalent Biologics Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Catalent Biologics Main Business
Table 92. Catalent Biologics Latest Developments
Table 93. FUJIFILM Diosynth Biotechnologies Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 94. FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Product Offered
Table 95. FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. FUJIFILM Diosynth Biotechnologies Main Business
Table 97. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 98. Made Scientific Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 99. Made Scientific Cell Therapy CMO Product Offered
Table 100. Made Scientific Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Made Scientific Main Business
Table 102. Made Scientific Latest Developments
Table 103. AGC Biologics Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 104. AGC Biologics Cell Therapy CMO Product Offered
Table 105. AGC Biologics Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. AGC Biologics Main Business
Table 107. AGC Biologics Latest Developments
Table 108. Pfizer CentreOne Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 109. Pfizer CentreOne Cell Therapy CMO Product Offered
Table 110. Pfizer CentreOne Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Pfizer CentreOne Main Business
Table 112. Pfizer CentreOne Latest Developments
Table 113. Samsung Biologics Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 114. Samsung Biologics Cell Therapy CMO Product Offered
Table 115. Samsung Biologics Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Samsung Biologics Main Business
Table 117. Samsung Biologics Latest Developments
Table 118. Kite Pharma, Inc. Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 119. Kite Pharma, Inc. Cell Therapy CMO Product Offered
Table 120. Kite Pharma, Inc. Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Kite Pharma, Inc. Main Business
Table 122. Kite Pharma, Inc. Latest Developments
Table 123. Kolon TissueGene, Inc. Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 124. Kolon TissueGene, Inc. Cell Therapy CMO Product Offered
Table 125. Kolon TissueGene, Inc. Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Kolon TissueGene, Inc. Main Business
Table 127. Kolon TissueGene, Inc. Latest Developments
Table 128. Novartis AG Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 129. Novartis AG Cell Therapy CMO Product Offered
Table 130. Novartis AG Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Novartis AG Main Business
Table 132. Novartis AG Latest Developments
Table 133. WuXi AppTec Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 134. WuXi AppTec Cell Therapy CMO Product Offered
Table 135. WuXi AppTec Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. WuXi AppTec Main Business
Table 137. WuXi AppTec Latest Developments
Table 138. Pharmaron Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 139. Pharmaron Cell Therapy CMO Product Offered
Table 140. Pharmaron Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 141. Pharmaron Main Business
Table 142. Pharmaron Latest Developments
Table 143. OBiO Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 144. OBiO Cell Therapy CMO Product Offered
Table 145. OBiO Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 146. OBiO Main Business
Table 147. OBiO Latest Developments
Table 148. Exothera Details, Company Type, Cell Therapy CMO Area Served and Its Competitors
Table 149. Exothera Cell Therapy CMO Product Offered
Table 150. Exothera Cell Therapy CMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 151. Exothera Main Business
Table 152. Exothera Latest Developments
LIST OF FIGURES
Figure 1. Cell Therapy CMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell Therapy CMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cell Therapy CMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cell Therapy CMO Sales Market Share by Country/Region (2025)
Figure 8. Cell Therapy CMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cell Therapy CMO Market Size Market Share by Type in 2025
Figure 10. Global Cell Therapy CMO Market Size Market Share by Cell Source in 2025
Figure 11. Global Cell Therapy CMO Market Size Market Share by Cell Types in 2025
Figure 12. Cell Therapy CMO in Commercial
Figure 13. Global Cell Therapy CMO Market: Commercial (2021-2026) & ($ millions)
Figure 14. Cell Therapy CMO in Academic Research
Figure 15. Global Cell Therapy CMO Market: Academic Research (2021-2026) & ($ millions)
Figure 16. Cell Therapy CMO in Others
Figure 17. Global Cell Therapy CMO Market: Others (2021-2026) & ($ millions)
Figure 18. Global Cell Therapy CMO Market Size Market Share by Application in 2025
Figure 19. Global Cell Therapy CMO Revenue Market Share by Player in 2025
Figure 20. Global Cell Therapy CMO Market Size Market Share by Region (2021-2026)
Figure 21. Americas Cell Therapy CMO Market Size 2021-2026 ($ millions)
Figure 22. APAC Cell Therapy CMO Market Size 2021-2026 ($ millions)
Figure 23. Europe Cell Therapy CMO Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Cell Therapy CMO Market Size 2021-2026 ($ millions)
Figure 25. Americas Cell Therapy CMO Value Market Share by Country in 2025
Figure 26. United States Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Cell Therapy CMO Market Size Market Share by Region in 2025
Figure 31. APAC Cell Therapy CMO Market Size Market Share by Type (2021-2026)
Figure 32. APAC Cell Therapy CMO Market Size Market Share by Application (2021-2026)
Figure 33. China Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 37. India Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Cell Therapy CMO Market Size Market Share by Country in 2025
Figure 40. Europe Cell Therapy CMO Market Size Market Share by Type (2021-2026)
Figure 41. Europe Cell Therapy CMO Market Size Market Share by Application (2021-2026)
Figure 42. Germany Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 43. France Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Cell Therapy CMO Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Cell Therapy CMO Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Cell Therapy CMO Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 56. APAC Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 57. Europe Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 59. United States Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 60. Canada Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 61. Mexico Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 62. Brazil Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 63. China Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 64. Japan Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 65. Korea Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 67. India Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 68. Australia Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 69. Germany Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 70. France Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 71. UK Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 72. Italy Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 73. Russia Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 74. Egypt Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 75. South Africa Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 76. Israel Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 77. Turkey Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 78. Global Cell Therapy CMO Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Cell Therapy CMO Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 1. Cell Therapy CMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell Therapy CMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cell Therapy CMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cell Therapy CMO Sales Market Share by Country/Region (2025)
Figure 8. Cell Therapy CMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cell Therapy CMO Market Size Market Share by Type in 2025
Figure 10. Global Cell Therapy CMO Market Size Market Share by Cell Source in 2025
Figure 11. Global Cell Therapy CMO Market Size Market Share by Cell Types in 2025
Figure 12. Cell Therapy CMO in Commercial
Figure 13. Global Cell Therapy CMO Market: Commercial (2021-2026) & ($ millions)
Figure 14. Cell Therapy CMO in Academic Research
Figure 15. Global Cell Therapy CMO Market: Academic Research (2021-2026) & ($ millions)
Figure 16. Cell Therapy CMO in Others
Figure 17. Global Cell Therapy CMO Market: Others (2021-2026) & ($ millions)
Figure 18. Global Cell Therapy CMO Market Size Market Share by Application in 2025
Figure 19. Global Cell Therapy CMO Revenue Market Share by Player in 2025
Figure 20. Global Cell Therapy CMO Market Size Market Share by Region (2021-2026)
Figure 21. Americas Cell Therapy CMO Market Size 2021-2026 ($ millions)
Figure 22. APAC Cell Therapy CMO Market Size 2021-2026 ($ millions)
Figure 23. Europe Cell Therapy CMO Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Cell Therapy CMO Market Size 2021-2026 ($ millions)
Figure 25. Americas Cell Therapy CMO Value Market Share by Country in 2025
Figure 26. United States Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Cell Therapy CMO Market Size Market Share by Region in 2025
Figure 31. APAC Cell Therapy CMO Market Size Market Share by Type (2021-2026)
Figure 32. APAC Cell Therapy CMO Market Size Market Share by Application (2021-2026)
Figure 33. China Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 37. India Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Cell Therapy CMO Market Size Market Share by Country in 2025
Figure 40. Europe Cell Therapy CMO Market Size Market Share by Type (2021-2026)
Figure 41. Europe Cell Therapy CMO Market Size Market Share by Application (2021-2026)
Figure 42. Germany Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 43. France Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Cell Therapy CMO Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Cell Therapy CMO Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Cell Therapy CMO Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Cell Therapy CMO Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 56. APAC Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 57. Europe Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 59. United States Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 60. Canada Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 61. Mexico Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 62. Brazil Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 63. China Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 64. Japan Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 65. Korea Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 67. India Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 68. Australia Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 69. Germany Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 70. France Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 71. UK Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 72. Italy Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 73. Russia Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 74. Egypt Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 75. South Africa Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 76. Israel Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 77. Turkey Cell Therapy CMO Market Size 2027-2032 ($ millions)
Figure 78. Global Cell Therapy CMO Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Cell Therapy CMO Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Cell Therapy CMO Market Size 2027-2032 ($ millions)
